Federated Hermes’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Federated Hermes’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,323	Closed	-$646K	–	2247
2023 Q2	$646K	Sell	15,323 -649,660	-98%	-$26.3M	﹤0.01%	1281
2023 Q1	$23.7M	Sell	664,983 -28,006	-4%	-$1.02M	0.06%	343
2022 Q4	$25.4M	Buy	692,989 +612,816	+764%	+$24.2M	0.07%	329
2022 Q3	$3.78M	Buy	80,173 +34,086	+74%	+$2.2M	0.01%	734
2022 Q2	$3.3M	Buy	46,087 +3,133	+7%	+$229K	0.01%	795
2022 Q1	$3.48M	Buy	42,954 +10,310	+32%	+$872K	0.01%	868
2021 Q4	$3.35M	Sell	32,644 -3,267	-9%	-$314K	0.01%	929
2021 Q3	$3.14M	Sell	35,911 -13,914	-28%	-$1.26M	0.01%	932
2021 Q2	$4.46M	Sell	49,825 -13,135	-21%	-$1.11M	0.01%	867
2021 Q1	$4.78M	Sell	62,960 -196	-0.3%	-$14.8K	0.01%	867
2020 Q4	$4.3M	Sell	63,156 -20,603	-25%	-$1.28M	0.01%	847
2020 Q3	$4.45M	Sell	83,759 -9,394	-10%	-$559K	0.01%	759
2020 Q2	$5.43M	Buy	93,153 +10,817	+13%	+$581K	0.01%	694
2020 Q1	$3.25M	Sell	82,336 -50,719	-38%	-$2.97M	0.01%	750
2019 Q4	$7.91M	Buy	133,055 +13,340	+11%	+$717K	0.02%	652
2019 Q3	$6.37M	Buy	119,715 +61,619	+106%	+$3.16M	0.02%	707
2019 Q2	$2.97M	Buy	58,096 +36,454	+168%	+$1.7M	0.01%	941
2019 Q1	$1.12M	Buy	21,642 +1,242	+6%	+$60.2K	﹤0.01%	1269
2018 Q4	$803K	Sell	20,400 -3,609	-15%	-$168K	﹤0.01%	1350
2018 Q3	$1.24M	Buy	24,009 +838	+4%	+$41K	﹤0.01%	1280
2018 Q2	$1.09M	Buy	23,171 +9,145	+65%	+$379K	﹤0.01%	1264
2018 Q1	$498K	Sell	14,026 -480	-3%	-$18.8K	﹤0.01%	1394
2017 Q4	$632K	Sell	14,506 -11,942	-45%	-$558K	﹤0.01%	1332
2017 Q3	$1.38M	Buy	26,448 +368	+1%	+$20.5K	﹤0.01%	1087
2017 Q2	$1.53M	Buy	26,080 +24,871	+2,057%	+$1.29M	﹤0.01%	1054
2017 Q1	$55K	Sell	1,209 -16,193	-93%	-$806K	﹤0.01%	1615
2016 Q4	$915K	Buy	17,402 +3,373	+24%	+$163K	﹤0.01%	1163
2016 Q3	$625K	Sell	14,029 -3,919	-22%	-$170K	﹤0.01%	1221
2016 Q2	$684K	Sell	17,948 -14,690	-45%	-$645K	﹤0.01%	1198
2016 Q1	$1.34M	Buy	32,638 +31,243	+2,240%	+$1.29M	﹤0.01%	993
2015 Q4	$68K	Buy	+1,395	New	+$62.1K	﹤0.01%	1632

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Federated Hermes's SYNH Position: Q3 2023 in Review

Federated Hermes sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 15,323 shares — an estimated $646K sold.

Federated Hermes first reported a position in SYNH in Q4 2015 and held it in 31 quarters. The position peaked at $25.4M in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Federated Hermes reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Federated Hermes sold 15,323 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $646K.
Federated Hermes first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 31 quarters.
Federated Hermes's Syneos Health, Inc. Class A Common Stock position peaked at $25.4M in Q4 2022.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.